Ashwath Jayagopal

CIK: 0002008983

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IRD

Opus Genetics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

IRD
Opus Genetics, Inc.
Apr 23, 2026
Sale(S)
Direct
7.5K shares at avg. $5.19$39K
IRD
Opus Genetics, Inc.
Mar 16, 2026
Sale(S)
Direct
3.7K shares at avg. $5.12$19K
IRD
Opus Genetics, Inc.
Feb 12, 2026
Tax Payment(F)
Direct
5.3K shares at avg. $3.39$18K
IRD
Opus Genetics, Inc.
Jan 22, 2026
Award(A)
Direct
400K shares-
IRD
Opus Genetics, Inc.
Mar 13, 2025
Award(A)
Direct
52.5K shares-
IRD
Opus Genetics, Inc.
Feb 13, 2025
Tax Payment(F)
Direct
5.2K shares at avg. $1.15$6K

		Type	Shares	Price		Ownership
Apr 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	7,542	$5.19	$39,156	Direct
Mar 16, 2026	IRD Opus Genetics, Inc.	Sale(S)	3,719	$5.12	$19,046	Direct
Feb 12, 2026	IRD Opus Genetics, Inc.	Tax Payment(F)	5,313	$3.39	$18,011	Direct
Jan 22, 2026	IRD Opus Genetics, Inc.	Award(A)	400,000	-	$0	Direct
Mar 13, 2025	IRD Opus Genetics, Inc.	Award(A)	52,500	-	-	Direct
Feb 13, 2025	IRD Opus Genetics, Inc.	Tax Payment(F)	5,193	$1.15	$5,972	Direct

1-6 of 6 transactions

About Jayagopal Ashwath

Jayagopal Ashwath (SEC CIK 0002008983) files insider reports with the SEC as Chief Scientific & Dev. Ofc. of Opus Genetics, Inc. (IRD).

Signal8 holds 6 ownership filings by Jayagopal Ashwath, all Form 4s, filed between Feb 18, 2025 and Apr 27, 2026. Those filings report 6 transactions, from Feb 13, 2025 to Apr 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jayagopal Ashwath's filings is in DURHAM, NC.

Recent filings by Jayagopal Ashwath

Apr 23, 2026: Open-market sale of IRD shares (Form 4, code S).
Mar 16, 2026: Open-market sale of IRD shares (Form 4, code S).
Feb 12, 2026: Tax withholding of IRD shares (Form 4, code F).
Jan 22, 2026: Grant or award of IRD shares (Form 4, code A).
Mar 13, 2025: Grant or award of IRD shares (Form 4, code A).

Other insiders filing for Opus Genetics, Inc. (IRD)

SCHACHLE JOSEPH K, Chief Operating Officer
YERXA BENJAMIN R, President
Gagnon Robert E., Chief Financial Officer
Magrath George, Chief Executive Officer
Foundation Fighting Blindness Retinal Degeneration Fund, Director
Gallagher Cam, Director

How to read Form 4 transaction codes